Effects of RAS inhibitors on diabetic retinopathy Reply

Thomas T. van Sloten^*, Coen D. A. Stehouwer

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	316-316
Journal	The Lancet Diabetes & Endocrinology
Volume	3
Issue number	5
DOIs	https://doi.org/10.1016/S2213-8587(15)00084-4
Publication status	Published - May 2015

Access to Document

@article{c6cdee9a65964c4abd1f6cc0e2d4813e,

title = "Effects of RAS inhibitors on diabetic retinopathy Reply",

author = "{van Sloten}, {Thomas T.} and Stehouwer, {Coen D. A.}",

year = "2015",

month = may,

doi = "10.1016/S2213-8587(15)00084-4",

language = "English",

volume = "3",

pages = "316--316",

journal = "The Lancet Diabetes & Endocrinology",

issn = "2213-8587",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - Effects of RAS inhibitors on diabetic retinopathy Reply

AU - van Sloten, Thomas T.

AU - Stehouwer, Coen D. A.

PY - 2015/5

Y1 - 2015/5

U2 - 10.1016/S2213-8587(15)00084-4

DO - 10.1016/S2213-8587(15)00084-4

M3 - Comment/Letter to the editor

SN - 2213-8587

VL - 3

SP - 316

EP - 316

JO - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

IS - 5

ER -